Search Results

OECD Nuclear Energy Agency and the United States to Co-Host "New Nuclear Roadmap 2026" Conference

The OECD Nuclear Energy Agency (NEA) and the United States will co-host the New Nuclear Roadmap 2026 conference on September 17-18, 2026, in Paris, France. The conference will bring together ministers, senior government representatives, industry leaders, investors, experts, and relevant stakeholders to discuss the policy, industrial, and financial conditions required for the large-scale deployment of new nuclear capacity. U.S. Secretary of Energy Chris Wright stated that the world needs more energy and that nuclear energy will play an important role in addressing this demand. The U.S. Department of Energy will co-host the conference with partners to advance nuclear innovation, strengthen international cooperation, and continue to promote global nuclear energy development...

2026-08-20

Maistop Completes Pre-A Round Financing to Advance Medical Radionuclide Industrialization via Electron Accelerator Method

August 12 news, Xi'an Maistop Technology Co., Ltd. recently completed its Pre-A round of financing, with investors including the Central Enterprise Strategic Emerging Fund and Guoxin Venture Capital Fund, both under China Reform Holdings Corporation. The proceeds from this round will primarily be used for site construction, equipment procurement, technology R&D, and daily operations. Founded in 2019, Maistop is a technology enterprise engaged in the R&D and production of medical radionuclides as well as nuclear medicine technical services. The company focuses on the preparation of medical radionuclides via the electron accelerator photonuclear reaction method, with core products including Actinium-225, Lead-212, Copper-67, and Molybdenum-99. Among these, Actinium-225 is a scarce radionuclide of significant interest in alpha-emitting nuclide targeted therapy, with relatively strong global clinical demand...

2026-08-13

UK Sizewell C Nuclear Power Station Financing Finalized, Project Worth Over £26 Billion to Supply Power for 60 Years

The Sizewell C nuclear power station project in the UK has completed its final financing arrangements, marking the official entry into the definitive construction phase of this large-scale nuclear project with a total investment target of approximately £38 billion, equivalent to around RMB 261 billion. Located on the Suffolk coast of England, the project will feature two EPR Generation III pressurised water reactor units, with a total installed capacity of approximately 3.2 gigawatts and a design operational lifespan expected to reach 60 years. This project holds significant importance for the UK's energy system. In recent years, the UK has faced the dual pressures of accelerating the phase-out of ageing fossil fuel infrastructure on one hand, and managing the variability of renewable energy and growing electricity demand on the other. Once completed, Sizewell C will provide long...

2026-08-10

StarRing Fusion Completes RMB 880 Million Series A++ Financing to Advance Fusion Device and Key Technology Engineering

StarRing Fusion recently announced the completion of a new Series A++ financing round, raising RMB 880 million. This round was jointly invested by Shenzhen Capital Group, Shendan Venture Capital, ABC Capital, BOCOM Investment, GGV Capital, Yongxin Ark, Keke Capital, Advantage Capital, and other institutions, with existing shareholder Shanghai Science and Technology Innovation Group's intellectual property fund and other institutions continuing to follow on. The company stated that the proceeds from this round, together with the previous Series A and A+ financing, will be used for the construction of the Shanghai Jiading experimental base, the construction and operation of the NTST negative-triangularity spherical tokamak, the design and construction of the CTRFR-1 "StarRing One," and the continued engineering advancement of key technologies including fusion-grade high-temperature superconducting magnets and AI-based plasma control...

2026-08-08

South Korea's Woori Technology Completes KRW 40 Billion Convertible Bond Financing to Bolster Nuclear Power and SMR Businesses

Woori Technology, a South Korean company specializing in nuclear power plant Man-Machine Interface Systems (MMIS) and related instrumentation and control equipment, announced on August 6 that it has decided to issue the 20th series of unregistered, unsecured private convertible bonds (CBs) totaling KRW 40 billion. The raised funds will be primarily used for nuclear power, small modular reactor (SMR), offshore wind power, and resource recycling businesses. The maturity date of these convertible bonds is August 13, 2031, with a conversion price of KRW 10,717 per share. Both the coupon rate and yield to maturity are 0%, which helps the company secure long-term funding for core business investments while controlling financial costs. Woori Technology stated that the raised funds...

2026-08-06

Valar Atomics Completes $1 Billion Equity Financing, Sequoia Capital Partner Joins Board

Nuclear energy startup Valar Atomics confirmed on August 3 that it has completed a $1 billion equity financing round led by Sequoia Capital. Company founder and CEO Isaiah Taylor stated that Sequoia Capital partner Shaun Maguire has joined the company's board of directors. In addition to the equity financing, Valar Atomics also secured a $200 million credit facility from Erebor and other banks. Valar Atomics did not disclose its post-financing valuation. Reports indicate the company is valued at approximately $6 billion. Valar Atomics primarily...

2026-08-04

BlueStar Fusion Completes "Angel+" Round Financing, High-Temperature Superconducting Stellarator Project Moves to Engineering Implementation Phase

Recently, Hefei BlueStar Fusion Technology Co., Ltd. (BlueStar Fusion, hereinafter referred to as "BlueStar Fusion") completed an Angel+ round of financing on the scale of several hundred million RMB, with a post-investment valuation exceeding 3 billion RMB. Following the completion of this financing round, the company will continue to advance the verification of key components, engineering manufacturing, and full-system integration of the high-temperature superconducting stellarator, with the goal of initiating the construction of the Phase I high-temperature superconducting stellarator system by 2027. BlueStar Fusion was established in August 2025 and is primarily engaged in the R&D and engineering of high-temperature superconducting stellarator technology. The company has assembled a professional team of nearly 100 members, covering fusion physics, superconducting magnets, structures and precision manufacturing, cryogenic engineering, artificial intelligence, and other disciplines. Ex...

2026-08-04

Ratio Therapeutics Completes $70 Million Series C Financing to Advance Clinical Development of Ac-225 Targeted Radiopharmaceuticals

Ratio Therapeutics, Inc., a U.S. clinical-stage pharmaceutical company, recently announced the completion of a $70 million Series C financing round. The company stated that following this round, its cumulative total financing has exceeded $240 million. According to the announcement, this round saw participation from existing investors Duquesne Family Office and Bristol Myers Squibb, while also bringing in new investors such as Catalio Capital Management, Eli Lilly and Company, and Wasatch Group. Ratio Therapeutics stated that the proceeds will be used to advance the clinical development of its targeted radiotherapeutic product pipeline and expand manufacturing infrastructure. The company plans to continue advancing the ATLAS study, which is evaluating its lead radiotherapeutic agent [Ac-2...

2026-08-03

Wuke Superconducting Completes Tens of Millions in Angel Round Financing, Accelerating the Industrialization of High-Temperature Superconducting Tapes

In late July 2026, Beijing Wuke Superconducting Technology Co., Ltd. (hereinafter referred to as "Wuke Superconducting") completed an angel round financing of tens of millions of RMB. This round was jointly invested by CASSTAR, Zhongguancun Capital, and Huairou Hard Technology Fund. The joint backing of several renowned venture capital institutions fully confirms the capital market's high recognition of Wuke Superconducting's core team, technical strength, and industry development prospects. Wuke Superconducting was initiated by the technical team of the Institute of Physics, Chinese Academy of Sciences, focusing on the R&D, preparation, and industrial application of a new generation of high-temperature superconducting tapes. The company is dedicated to overcoming the key bottlenecks in transitioning high-temperature superconducting materials from laboratory to large-scale application, building an integrated platform covering superconducting target development, core equipment R&D, high-performance tape preparation, and ultimate performance characterization of wires and tapes.

2026-08-03

Guomai Fusion Energy Completes Angel+ Round Financing, with Zhengxuan Investment and Others Supporting aFRC Fusion Route Commercialization

Recently, Beijing Guomai Fusion Energy Technology Co., Ltd. (hereinafter referred to as Guomai Fusion Energy) completed its Angel+ round of financing. This round was participated by well-known institutions such as Zhengxuan Investment and Dalin Investment. By adopting a strategy of small steps and rapid iteration, Guomai Fusion Energy has continuously advanced its financing, pooling industrial and capital forces to support R&D design and engineering validation, and promoting the fast and sound development of the advanced field-reversed configuration (aFRC) route. The funds from this round will be primarily used for aFRC route R&D, including the construction of fusion experimental devices, core technology breakthroughs, and talent team building, accelerating key technology breakthroughs and experimental validation. Guomai Fusion Energy, established in the Beijing Economic-Technological Development Area, is a company focusing on advanced field-reversed config...

2026-07-31

U.S. Fusion Energy Company CFS Completes $1 Billion Equity Financing

U.S. fusion energy startup Commonwealth Fusion Systems (CFS) announced on July 30 that it has completed $1 billion in new equity financing. The company stated that this is one of the largest single-round financings globally for a fusion energy company since its $1.8 billion Series B round in 2021. To date, CFS has raised a total of $4 billion, accounting for nearly 30% of the cumulative global fusion industry financing. Headquartered in Devens, Massachusetts, CFS was founded in 2018. The company is primarily advancing the SPARC fusion demonstration device and the ARC commercial fusion power plant project. Fusion reactions release energy by combining light atoms such as hydrogen under extremely high temperatures and pressures, and are considered a potential low-carbon energy pathway. However, fusion reactors are still in the experimental and engineering validation stage, with related technologies facing challenges such as material resistance to neutron bombardment and improving reaction efficiency.

2026-07-30